NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
51 hedge funds and large institutions have $32.9M invested in InVivo Therapeutics Holdings Corp in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
35% less capital invested
Capital invested by funds: $50.4M → $32.9M (-$17.5M)
91% less call options, than puts
Call options by funds: $35K | Put options by funds: $409K
Holders
51
Holding in Top 10
1
Calls
$35K
Puts
$409K
Top Buyers
| 1 | +$627K | |
| 2 | +$538K | |
| 3 | +$475K | |
| 4 |
Millennium Management
New York
|
+$462K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$227K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$700K | |
| 3 | -$367K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$183K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$41K |